Dispensary of Hope Delivers Free Medicines to Uninsured Patients

In this episode, Mark Cuban Cost Plus Drugs pharmacist Erin Albert, MBA, PharmD, JD, DASPL, sat down with Hillary Blackburn, PharmD, MBA, CEO of Dispensary of Hope, to explore how innovative pharmacy models are expanding medication access for uninsured and low-income patients across the United States. Blackburn shares her journey from growing up in rural Mississippi to leading a national nonprofit that connects donated medications from pharmaceutical manufacturers with free and charitable clinics, FQHCs, and safety-net pharmacies. She explains how Dispensary of Hope operates as a licensed wholesale distributor in all 50 states, using a secure supply chain to deliver high-quality medications at no cost to patients who might otherwise have to choose between paying for food, housing, or prescriptions.

They dove into powerful patient stories that illustrate the real-world impact of free medication access, including individuals managing mental health conditions, diabetes, and arthritis whose lives were transformed through consistent treatment. Albert and Blackburn also discuss evidence showing that reliable access to medications through Dispensary of Hope leads to fewer emergency room visits, reduced hospital readmissions, and significant cost savings for health systems, with peer-reviewed studies documenting improved outcomes and lower utilization.

Blackburn discussed how pharmacies and clinics enroll in the program, how the formulary and ordering system work, and clarifies how Dispensary of Hope operates independently of the 340B program while complementing other affordability initiatives like Mark Cuban Cost Plus Drugs. The episode also touched on Hilary’s experience as a “boomerang” employee returning to lead the organization, her commitment to women in pharmacy leadership, and her historic appointment as the first pharmacist voting member of the CDC’s vaccine advisory committee, where she brings a front-line access and public health perspective.

Together, they framed medication affordability as a spectrum and positioned Dispensary of Hope as a critical last-line safety net for patients with no other options.

“What I love about Dispensary of Hope is that it is so collaborative in nature. Health care can be a competitive arena. There's a lot of complexity, a lot of misaligned incentives,” Blackburn said. “You can get bogged down in in the tech or the industry norms or different silos, and so I just love that we're able to kind of represent that seemingly unnatural partnership of connecting the pharmaceutical companies with these free clinics.”